Slide 1: Q1 Investor Presentation
Q1 Investor Presentation May 2025
Slide 2: Disclosures
Disclosures Forward-Looking Statements This presentation may contain "forward-looking statements," which include information concerning Celanese Corporation’s (the “Company”) plans objectives, goals, strategies, future revenues, cash flow, financial performance, synergies, capital expenditures, dele
Slide 3: Discussion Topics
Discussion Topics Company Overview 2025 Actions Celanese Value Drivers 3
Slide 4: Celanese Company Snapshot
Celanese Company Snapshot . . . A global chemical and specialty materials company ~$10.3B ~$ 2.4B that develops and 2 2024 Operating EBITDA manufactures a broad set of 2024 Net Sales products essential to ~11,800 Dallas 1 * everyday living Global Employees Global Headquarters 1. Approximate global h
Slide 5: Committed to taking bold action to reestablish industry leadership and growth track record
Committed to taking bold action to reestablish industry leadership and growth track record Operating EBITDA ($B) * + 7% CAGR We are committed to: 2.8 2.6 2.4 2.4 2.2 1.6 1.6 1.7 1.8 → Reestablishing consistent earnings growth 1.4 1.5 1.5 1.3 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 202
Slide 6: Q1 2025 Results and Q2 Outlook
Q1 2025 Results and Q2 Outlook Q1 2025 Results Q2 2025 Outlook Q1 adjusted EPS* $0.57 vs. guidance of $0.25 – $0.50 Q2 adjusted EPS* guidance $1.30 - $1.50 per share Q1 Free Cash Flow* of ($73M) vs. guidance of ($300M) Q1 2025 Highlights Q2 2025 Drivers Better than expected mix vs. guide due to slig
Slide 7: Advancing strategic priorities to realize Celanese's potential in the near-term
Advancing strategic priorities to realize Celanese’s potential in the near-term with a focus on self-help actions INCREASE CASH INTENSIFY COST DRIVE TOP-LINE FLOW IMPROVEMENTS GROWTH to by through deleverage the maximizing supercharging the pipeline & balance sheet productivity everyday industry opp
Slide 8: Actions Underway
2025 initiatives are building on actions that have been taken INCREASE CASH INTENSIFY COST DRIVE TOP LINE FLOW IMPROVEMENT GROWTH Previous Actions 11,792 03/31/2025 F Completed refinancing of certain debt $80 million in 2025 SG&A cost Utilize global capabilities to win in Actions Underway maturities
Slide 9: Our Commitment to Deleveraging
Our Commitment to Deleveraging Actively pursuing additional divestiture “One of the greatest value drivers opportunities to advance deleveraging – for Celanese shareholders at this targeting ~$1B in next 2.5 years time comes from aggressively and Reduced the common stock dividend prudently deleverag
Slide 10: Key actions expected to deliver higher YoY Free Cash Flow
Key actions expected to deliver higher YoY Free Cash Flow* FY 2025 Estimated Free Cash Flow* ($M) FY2025 vs FY2024 Free Cash Flow* Generation $ 800M Assuming minimal → Working Capital improvements ~40% - ~60 % $ 700M further demand of + $230M to $280M impact from tariffs → Capital expenditures reduc
Slide 11: Demonstrated strength in Free Cash Flow generation
Demonstrated strength in Free Cash Flow generation Free Cash Flow1 2020A – 2025F ($M) Free Cash Flow Yield2 Comparison History of strong free cash flow generation … … and attractive free cash flow yield $1,320 14% $1,263 $1,263 $950 8% $700 7% to $498 $800 2020 2021 2022 2023 2024 2025F 2023 2024 20
Slide 12: The refinancing transaction completed in March 2025 improved the maturity profile
The refinancing transaction completed in March 2025 improved the maturity profile $2,860 M Refinancing Transactions $400 M Cross Currency Swap $2,610 M bond issuance $400 M JPY / USD swap $250 M net draw on 364-day delayed draw term loan 3.8 ⟩ 4.8 years $2.8 ⟩ $1.1 billion Transaction AVG. DEBT MATU
Slide 13: Maturities are aligned with cash flow generation capabilities
Maturities are aligned with cash flow generation capabilities Debt Maturity Profile: Pre-Refinancing and Post-Refinancing Targeting to address maturities through 2027 with free cash flow and divestiture proceeds Cash Generation Drivers Pre1 Post → Self-help actions increase earnings and free cash fl
Slide 14: Cost reduction actions expected to deliver ~$120M savings in 2025
Cost reduction actions expected to deliver ~$120M savings in 2025 2025 Priorities 2025 Key Actions Implemented and Planned Workforce Reductions $80 million in SG&A cost reductions actioned in January SG&A as % of sales in EM reduced ~85 bps YoY and expected to be realized in 2025 13,263 11% 12,410 1
Slide 15: Driving dedicated actions to address nylon 6,6 margin compression
Driving dedicated actions to address nylon 6,6 margin compression EM Adjusted Gross Profit* 2024 v 2021 Between 2021 and 2024 EM adjusted gross profit* fell by approximately $350M Adjusted gross profit* decline in nylon 6,6 accounted for nearly three quarters of that total Nylon Earnings Expansion ~
Slide 16: EM growth is amplified by High Impact Programs
EM growth is amplified by High Impact Programs Quality Programs 2025 Key Actions Average Value per Project - 2025 +20 % Focus on High Impact Programs (HIP): high performance, BASE PROGRAMS demanding projects that drive higher margin HIGH IMPACT PROGRAMS Align resources with priorities and leverage p
Slide 17: Manufacturing network flexibility with localized production support tariff mitigation options
Manufacturing network flexibility with localized production support tariff mitigation options Vast Majority of Sales, Production, and Purchasing In Region Multiple Mitigation Options U.S. China Operations 2024 Sales: ~$2.7B 2024 Sales: ~$2.0B → Flexing unique product and global footprint to mitigate
Slide 18: Why Celanese? Compelling Drivers of Value Creation
Why Celanese? Compelling Drivers of Value Creation LEADING MARKET ATTRACTIVE END LONG-TERM POSITION MARKETS GROWTH with structurally regional presence driven by unique business with diverse end- innovation and models markets and aligned with customers megatrends 18
Slide 19: Acetyl Chain: highly diverse mix across product, end-market, and geographies
Acetyl Chain: highly diverse mix across product, end-market, and geographies Acetyls chemistry supports everyday life Food & Building & Medical & Automotive & Packaging & Agriculture Construction Pharmaceutical Industrials Paper • Food additives • Paints & coatings • Medicine production • Safety gla
Slide 20: Global Acetyls leader with an integrated value chain
Global Acetyls leader with an integrated value chain Leverage unique integrated global product chain and advantaged cost position to predict and adapt to global dynamics and trends 1 2 4 5 6 Carbon Acetic Acid VAM Emulsions Powders Monoxide Significant Advantages with Chain Optionality 1 Anhydride &
Slide 21: EM offers an industry leading portfolio of polymer solutions
EM offers an industry leading portfolio of polymer solutions LCP Vectra® | Zenite® Performance Broad Polymer Portfolio Polymers PPS Fortron® High PPA Frianyl® XT | Celanyl® XT | Zytel® PCT Thermx® 25-30 Universe of Engineered Polymers LCPA Zytel® ~19 Celanese Engineered Materials PA 66 Frianyl® | Ce
Slide 22: Engineered Materials well positioned for growth
Engineered Materials well positioned for growth High Impact Programs and technology innovation are aligned with megatrends Automotive Medical Electrification Footwear & Apparel • Battery and Thermal • Medical devices and • Connectivity • Athletic footwear • E-motors and Power equipment • Power Gener
Slide 23: Highly diversified end-markets supported by extensive global reach
Highly diversified end-markets supported by extensive global reach Headquarter Manufacturing Business Mix by Net Sales (2024) Manufacturing Footprint Commercial center Joint Ventures Lab Meyrin, Switzerland (HQ) Regional HQ By end market Distribution and other Automotive Other Construction Medical D
Slide 24: Current undervaluation provides opportunity for long-term growth
Current undervaluation provides opportunity for long-term growth Attractive valuation with upside potential for stock Forward Looking P/E Multiple – Select Chemical Industry Companies Avg. 15.8x 33.0x 29.6x 21.8x 20.5x 19.0x 18.5x 16.0x 15.5x 13.9x 13.3x 13.2x 12.8x 12.7x 12.3x 11.2x 10.5x 10.1x 8.9
Slide 25: Celanese Offers a Compelling Investment Opportunity
Celanese Offers a Compelling Investment Opportunity Our mission is to position Celanese New leadership driving Actions underway to Strong earnings as a top quartile change deliver near-term leverage as demand company for total earnings improvement recovers shareholder return by delivering earnings g